EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Open Access · CC BY-NC-ND 4.0

Predictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy

Robert C Sergott, Valerio Carelli, Nancy J Newman, Valérie Biousse, Patrick Yu-Wai-Man, Catherine Vignal-Clermont, Constant Josse, Magali Taiel, José-Alain Sahel, Piero Barboni, LHON Study Group

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.9.42 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Robert C Sergott und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Ophthalmology and Neurology, Wills Eye Hospital; William H. Annesley, Jr., EyeBrain Center, Thomas Jefferson University, Philadelphia,…. Hauptthemen laut MEDLINE: Optic Atrophy, Hereditary, Leber, Visual Acuity, Genetic Therapy, DNA, Mitochondrial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Optic Atrophy, Hereditary, LeberVisual AcuityGenetic TherapyDNA, MitochondrialHumansMaleFemaleTomography, Optical CoherenceAdultAdolescentYoung AdultTreatment OutcomeRetinal Ganglion CellsMiddle AgedChildMutationGenetic VectorsNerve FibersFollow-Up StudiesNADH Dehydrogenase

Substanzen

NADH dehydrogenase subunit 4DNA, MitochondrialNADH Dehydrogenase

Autor:innen und Institutionen

  • Departments of Ophthalmology and Neurology, Wills Eye Hospital; William H. Annesley, Jr., EyeBrain Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.
  • IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy.
  • Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
  • Departments of Ophthalmology, Neurology and Neurological Surgery, Emory University School of Medicine, Atlanta, Georgia, United States.
  • Cambridge Centre for Brain Repair and MRC Mitochondrial Biology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
  • Cambridge Eye Unit, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, United Kingdom.

Zitieren

APA

Sergott, R. C., Carelli, V., Newman, N. J., Biousse, V., Yu-Wai-Man, P., Vignal-Clermont, C., Josse, C., Taiel, M., Sahel, J. A., Barboni, P., & LHON Study Group (2025). Predictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.9.42

Vancouver

Sergott RC, Carelli V, Newman NJ, Biousse V, Yu-Wai-Man P, Vignal-Clermont C, et al. Predictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.9.42

BibTeX
@article{Sergott2025,
  author = {Sergott, Robert C and Carelli, Valerio and Newman, Nancy J and Biousse, Valérie and Yu-Wai-Man, Patrick and Vignal-Clermont, Catherine and Josse, Constant and Taiel, Magali and Sahel, José-Alain and Barboni, Piero and LHON Study Group, LHON Study Group},
  title = {Predictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.9.42}
}
Kostenlos starten →